The results published so far have considered the effect of the relationships of polymorphisms in the promoter region of the basic fibroblast growth factor gene with proliferative diabetic retinopathy [16] or myocardial infarction [15] in patients with type 2 diabetes. This evidence concerns the gene FGF2 and myocardial infarction.